The NICE consultation raised more questions than it answers.  It is, however, an opportunity to develop the NICE methodology so that it better takes account of the severity of a disease, as well as the effect that conditions have on patients’ capacity to engage in society.

PruceConsulting have produced a detailed report on the NICE proposals outlining: -

• What the proposed changes are
• The new measures and the challenges with them
• Advantages and disadvantages with the proposals
• The unanswered questions
• What you should do now
• The report also contains case studies identifying some of the challenges

Extensively referenced, this report explains what you need to know about value based assessments and the potential impact.  It is a must for everyone involved in technology appraisals whether you are from the pharmaceutical industry; a patient group; a health economist; a clinician or a policy maker.  

You can download the Executive Summary for free by clicking this link.

The full report can be purchased from PruceConsulting using PayPal or credit/debit cards by clicking the button below. 

PruceConsulting Limited offers three different types of licence agreement for publications.

1. Single user licence - This covers the person placing the order only. Circulation to third parties is not permitted.

2. Corporate licence - This covers all employees in one country within the organisation placing the order. Circulation to third parties is not permitted.

3. Global licence - This covers all employees worldwide within the organisation placing the order. Circulation to third parties is not permitted.